ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,062.00
-0.10%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36074
-0.04%
Bitcoin
66,277.51
-0.99%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Omega Therapeutics Inc (OMGA)

  7. Omega Therapeutics Inc (OMGA) News

OMGA

Omega Therapeutics (OMGA)

Omega Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OMGA
DateTimeSourceHeadlineSymbolCompany
05/08/20246:00AMGlobeNewswire Inc.Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic ControllersNASDAQ:OMGAOmega Therapeutics Inc
05/06/20246:06AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OMGAOmega Therapeutics Inc
05/06/20246:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMGAOmega Therapeutics Inc
05/06/20246:00AMGlobeNewswire Inc.Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:OMGAOmega Therapeutics Inc
04/23/20246:00AMGlobeNewswire Inc.Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual MeetingNASDAQ:OMGAOmega Therapeutics Inc
04/09/20246:00AMGlobeNewswire Inc.Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic ControlNASDAQ:OMGAOmega Therapeutics Inc
03/28/20248:15AMGlobeNewswire Inc.Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic UpdateNASDAQ:OMGAOmega Therapeutics Inc
03/06/20246:00AMGlobeNewswire Inc.Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024NASDAQ:OMGAOmega Therapeutics Inc
02/09/20244:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMGAOmega Therapeutics Inc
02/09/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMGAOmega Therapeutics Inc
02/09/20243:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMGAOmega Therapeutics Inc
01/05/20243:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMGAOmega Therapeutics Inc
01/02/20243:05PMGlobeNewswire Inc.Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:OMGAOmega Therapeutics Inc
12/11/20233:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMGAOmega Therapeutics Inc
12/04/20233:00PMGlobeNewswire Inc.Omega Therapeutics to Participate in the H.C. Wainwright 4th Annual Precision Oncology Virtual ConferenceNASDAQ:OMGAOmega Therapeutics Inc
11/27/20236:01PMPR Newswire (US)Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science LeadersNASDAQ:OMGAOmega Therapeutics Inc
11/21/20235:00AMPR Newswire (US)Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of GeneticsNASDAQ:OMGAOmega Therapeutics Inc
11/20/20233:00PMGlobeNewswire Inc.Omega Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:OMGAOmega Therapeutics Inc
11/13/20236:00AMGlobeNewswire Inc.Omega Therapeutics Showcases Bidirectional and Multiplexed Epigenomic Control of Gene Expression in Preclinical Models of Liver Inflammation and FibrosisNASDAQ:OMGAOmega Therapeutics Inc
11/09/20236:03AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OMGAOmega Therapeutics Inc
11/09/20236:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMGAOmega Therapeutics Inc
11/09/20236:00AMGlobeNewswire Inc.Omega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:OMGAOmega Therapeutics Inc
11/07/20233:00PMGlobeNewswire Inc.Omega Therapeutics to Participate in The Jefferies London Healthcare ConferenceNASDAQ:OMGAOmega Therapeutics Inc
10/31/20236:00AMGlobeNewswire Inc.Omega Therapeutics Presents New Preclinical Data Demonstrating Pre-Transcriptional Modulation of Multiple CXCL Genes by a Single Epigenomic ControllerNASDAQ:OMGAOmega Therapeutics Inc
10/16/20236:00AMGlobeNewswire Inc.Omega Therapeutics Presents New Preclinical Data Supporting the Potential of OTX-2101 in Combination Settings for Treatment of NSCLCNASDAQ:OMGAOmega Therapeutics Inc
10/11/20233:00PMGlobeNewswire Inc.Omega Therapeutics Announces Two Poster Presentations on Liver Inflammation and Fibrosis at AASLD’s The Liver Meeting® 2023NASDAQ:OMGAOmega Therapeutics Inc
10/04/20233:00PMGlobeNewswire Inc.Omega Therapeutics to Present New Preclinical Data on OTX-2101 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsNASDAQ:OMGAOmega Therapeutics Inc
09/26/20234:29PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMGAOmega Therapeutics Inc
09/26/20236:00AMGlobeNewswire Inc.Omega Therapeutics Announces Promising Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I TrialNASDAQ:OMGAOmega Therapeutics Inc
09/25/20233:00PMGlobeNewswire Inc.Omega Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial on September 26NASDAQ:OMGAOmega Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:OMGA

Your Recent History

BIT
UB5FUG
Unicredit Bank
EU
P132S
P132S
AMEX
BSJM
Invesco BulletShares 202...
NASDAQ
FALWX
Franklin Income Allocati...
COIN
QBEETH
LSE
80MK
Orbit 38
USOTC
CHPGF
Chesapeake Gold (QX)
LSE
82PG
Orig.ml.m6 32
BIT
S28948
Societe Generale Effekten
LBNK
DESOUSDT
Decentralized Social
COIN
GTOETH
Gifto [OLD]
HITB
SURUSD
Suretly [Ethereum]
NYSE
FTAI-B
Fortress Transportation ...
TG
B5K3
ThreeD Capital
USOTC
SAEI
Supatcha Resources (CE)
LSE
YJ18
Onward Homes 53
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved